2017
The Significance of Upfront Knowledge of N2 Disease in Non‐small Cell Lung Cancer
Thomas DC, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. The Significance of Upfront Knowledge of N2 Disease in Non‐small Cell Lung Cancer. World Journal Of Surgery 2017, 42: 161-171. PMID: 28799084, DOI: 10.1007/s00268-017-4165-6.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerUnsuspected N2 diseaseIII-N2 non-small cell lung cancerN2 diseaseCell lung cancerSurgical resectionAdjuvant chemotherapyAdjuvant therapyOverall survivalPathologic stageLung cancerMultivariate analysisCurative-intent surgical resectionStage IIIA NSCLCHigher comorbidity scoreNational Cancer DatabaseIndependent risk factorKaplan-Meier analysisCN2 diseaseIIIA NSCLCComorbidity scoreCancer DatabaseRisk factorsRetrospective analysisRadiation therapy
2015
The Surgical Apgar Score in esophagectomy
Janowak CF, Blasberg JD, Taylor L, Maloney JD, Macke RA. The Surgical Apgar Score in esophagectomy. Journal Of Thoracic And Cardiovascular Surgery 2015, 150: 806-812. PMID: 26234458, DOI: 10.1016/j.jtcvs.2015.07.017.Peer-Reviewed Original ResearchConceptsSurgical Apgar ScoreMajor morbidityApgar scorePostoperative complicationsMultivariate analysisPreoperative patient characteristicsShort-term outcomesBody mass indexStrongest predictorElective esophagectomyTranshiatal techniqueSurgical populationIntraoperative detailsIntraoperative variablesPatient characteristicsDiabetes mellitusPrimary outcomeRetrospective reviewMass indexProspective studyCare modificationsMalignant diseaseRisk factorsUnivariate analysisImproved outcomes
2009
Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer (NSCLC)
Blasberg J, Pass H, Flores R, Donington J. Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2009, 27: 11019-11019. DOI: 10.1200/jco.2009.27.15_suppl.11019.Peer-Reviewed Original ResearchNon-small cell lung cancerEarly-stage non-small cell lung cancerStage non-small cell lung cancerEarly-stage NSCLC patientsStage NSCLC patientsPlasma osteopontin levelsNSCLC patientsOPN levelsPlasma OPNOsteopontin levelsIndependent cohortElevated Plasma Osteopontin LevelsStage I patientsImpact of surgeryCell lung cancerResectable NSCLC patientsSignificant decreaseNSCLC correlatesFormer smokersI patientsPrognostic significanceValidation cohortLung cancerPatientsMultivariate analysis